Hyperlipidemia often occurs after renal transplantation and may contribute to increased cardiovascular morbidity. The National cholesterol education program guidelines (NCEP) recommend dietary modification as the initial therapeutic intervention. We evaluated the effects of the AHA Step I and Step II diets on the serum total cholesterol (TC) and the triglyceride (TG) levels in nondiabetic renal transplant patients. Both the AHA Step I (TC 296 ± 7 vs 294 ± 9 mg/dL, p = ns) and Step II diets (TC 282 ± 8 vs 292 ± 16 mg/dL, p = ns) failed to significantly lower the serum total cholesterol and the triglycerides levels. During this dietary intervention, the patients' body weight and serum creatinine level remained stable. Our data suggest that neither the AHA Step 1 nor the Step II diet are effective in significantly lowering elevated serum lipids in nondiabetic renal transplant recipients.
FassbinderW., ChallahS., BryngerH.. On behalf of the EDTA Registry. Long term results of renal transplantation in Europe.Transplant Proc1987; XIX(5): 3754–7.
6.
Editorial: Hyperlipidemia after renal transplantation.Lancet1988; 1: 919–20.
7.
MarkellM.S., FriedmanE.A.. Hyperlipidemia after organ transplantation.M J Med1989; 87: (5N): 61–7N.
8.
Expert panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults.Arch Intern Med1988; 148: 36–69.
9.
CastelliW.P., DoyleJ.T., GordonT.HDL Cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotype Study.Circulation1977; 55: 767–72.
10.
RhoadsG.G., GulbrandsonC.L., KaganA.. Serum lipoprotein and coronary heart disease in a population of Hawaii Japanese men.N Engl J Med1976; 294: 293–8.
11.
Lipid Research Clinics Program.The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.JAMA1984; 251: 365–74.
12.
GroenJ., TjiongB.K., ChammingaC.E.. The influence of nutrition, individuality and some other factors, including various forms of stresses, on the serum cholesterol: an experiment of nine months' duration in 60 normal volunteers.Voeding1952; 13: 556–87.
13.
AndersonJ.W., GustafsonN.J.. Alternative lipid-lowering diets.Practical Cardiology1988; (14) 1: 84–97.
14.
SchaeferE.J.. When and how to treat the dyslipidemias.Hospital Practice Jan198869–84.
15.
GinsbergH.N., BarrS.L., GilbertA.Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat.N Engl J Med1990; 322: 574–9.
16.
MooreR.A., CallahanM.F., CodyM.The effects of the American Heart Association Step 1 diet on hyperlipidemia following renal transplantation.Transplant1990; 49: 60–2.
17.
ShenS.Y., LukensC.W., AlongiS.V., SfeirR.E., DagertF.J., SadlerJ.H.. Patient profile and effect of dietary therapy on post transplant hyperlipidemia.Kidney Int1983; 24: S147–52.
18.
NelsonJ., BeauregardH., GelinasM.Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet.Transplant Proc1988; 20: 1264–70.
19.
KasiskeB., TortoriceK.L., Heim-DuthoyK.L., GoryanceJ.M., RaoK.V.. Lovastatin treatment of hypercholesterolemia in renal transplant recipients.Transplant1990; 49(1): 95–100.
20.
YoshimuraN., OkaT., OkamotoM., OshmoriY.. The effects of pravastatin on hyperlipidemia in renal transplant recipients.Transplant1992; 53(1): 94–9.
MoorheadJ.F., ChanM.K., El-NahasM., VargheseZ.. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease.Lancet1982; 2: 1309–11.
23.
LalS.M., PetroskiG.F., HewettJ.E.Long term lipid lowering effects of nicotinic acid and lovastatin in renal transplant patients, JASN1993; 4(3): 946.
24.
MensinkR.P., KatanM.B.. Effect of a diet enriched with monosaturated or polyunsaturated fatty acids on levels of low density and high density lipoprotein cholesterol in healthy women and men.N Engl J Med1989; 321: 463–41.
25.
Martinez-HernandezB., PersaudJ.W., VargheseZ., MoorheadJ.F.. Low dose simvastatin is safe in hyperlipidemic transplant patients treated with cyclosporine.JASN1992; 3: 869.
26.
KnightR., VathsalaA., SchoenbergL.Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.Transplant1992; 53: 224–5.
27.
GonyeaJ.E., AndersonC.F.. Weight change and serum lipoproteins in recipients of renal allografts.Mayo Clin Proc1992; 67: 653–7.
28.
ArntzeniusA.C., Kromhout, BarthJ.D., EiberJ.H.C.. Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.N Engl J Med1985; 312: 805–11.
29.
HunninghakeD.B., SteinE.A., DujovneC.A., HarrisW.S.The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.N Engl J Med1993; 328: 1213–9.
